From private practice to an institutional balance sheet — on your terms.
Institutional buyers buy one asset, not twenty separate businesses. The capital wanted in. The infrastructure to read twenty independent practices as one asset just didn't exist.
01.1 — The reporting layer
An enterprise resource planning system (ERP) consolidates the financial reporting of every practice in the portfolio into a single, institutional-grade view. Twenty practices, twenty sets of books, one unified income statement that an institutional buyer can underwrite as a single asset.
01.2 — The credibility layer
On top of the ERP sits a full PCAOB audit — the same standard public companies are held to. One audit covers all twenty practices. Individually that would cost each doctor $30,000–$50,000 — inside the portfolio, it's absorbed by the deal structure. You get institutional credibility without the bill.
01.3 — The protection layer
Your practice plugs into infrastructure that's already audit-ready, KYC-compliant, and built to the standards buyers require — without changing anything about how you run your practice day-to-day.
01.4 — The neutrality layer
Zenyte Holdings is built as a neutral aggregator — a structure designed to bring you directly to portfolio buyers without inserting itself into your equity. Every doctor whose practice fits a portfolio's spec has the same access. The upside on what you've built stays with you — the downside to participating with us is zero.
Your practice doesn't have to become institutional. The portfolio is the institution.
EXAMPLE PORTFOLIO: 8 DENTAL · 6 VETERINARY · 4 PRIMARY CARE · 2 SPECIALTY
Healthcare revenue is one of the most-bought asset classes in institutional finance. Pension funds buy it for stability. Sovereign wealth buys it for inflation resistance. Tech-adjacent vehicles buy it as a hedge against pure-growth exposure. Insurance companies buy it for predictable income to match against future liabilities. The demand isn't one buyer with one mandate — it's dozens of sophisticated capital pools, each buying healthcare revenue for a different reason.
Your practice isn't being marketed speculatively. It's being matched to a portfolio that's already in demand — built around a specific buyer with specific intent.
That sophistication on the buyer side is what unlocks optionality on yours. Because the buyers are diverse, what they're willing to pay you in is diverse too. Cash. Equity in a publicly-traded vehicle. Treasury-backed income. Exposure to a high-growth strategy. Or a custom combination built for your situation.
In a market this regulated, the question isn't “will I get paid” — it's what you want to be paid in, given everything you're trying to do with this chapter of your life.
For doctors who want a cash-based liquidity event.
Whatever portion you sell, you take in cash. Deploy it however you choose — retirement, real estate, the next venture, your kids' future.
For doctors who want continued exposure to what they helped build.
Convert your slice into shares of an institutionally-backed, publicly-traded portfolio vehicle. Liquidity at your discretion. Upside tied to the same vehicle pension funds and sovereign wealth are holding.
For doctors who prioritize certainty over upside.
Defined-term income with the same tax advantages as the other paths. The lowest-risk, longest-horizon option — designed for stability over speed.
For doctors who want to build something, not just exit.
Some buyers want more than financial exposure. Tech-aligned vehicles, platform builders, strategic acquirers — they're looking for practices that fit a specific operational thesis. We structure custom deals when the fit calls for it.
For doctors who've watched these deals from outside and wanted in.
These are the deals that get talked about for years. Unique structure, unique buyers, technology that's never been packaged this way before. When they show up, we're all ready to go tomorrow.
For doctors who understand that the real answer is rarely one thing.
Take partial cash, partial equity, hold a piece for a bigger play — combined in whatever proportions you choose. The flexibility is the entire point of what we built. Your deal fits your life, not a template.
A buyer can't write a check for a single $1M practice. It's too small for them, and the accounting work to get the deal done costs more than the deal is worth. Twenty practices in one portfolio? That's the size they buy.
Aggregation is what unlocks portfolio pricing. Each practice keeps its own operations, its own brand, its own patients, its own clinical decisions. What gets bundled together is the revenue — the steady cash flow institutional buyers pay a premium for.
These aren't hypothetical examples — these are real opportunities. We are actively assembling portfolios to meet the demand of the market — our next deal closing this fall.
10% stakes·Multiple buyers·Ongoing liquidity
Ongoing
There's a steady stream of buyers competing for 10% stakes in our portfolios. More often than not, you will be reviewing fresh offers to take some more off the table. Take it or leave it. Your call. Over time, you can vest your practice as you please — no single large exit required.
Sell 25%·$1M+ practice·$1M in your pocket — Keep 75%
Closes Fall 2026
Sell a quarter and take a $1 million payday. The other 75% you own as publicly-traded shares in the same portfolio the world's largest financial institutions are buying — yours to sell whenever the timing fits. Same patients. Same staff. Same building. You still run the practice exactly as you did yesterday.
$1M practice shown as an example — the math scales with your size.
Sell 100%·$500K+ practice·Post-sale passive income
Closes Fall 2026
Would you take U.S. Treasury bonds in exchange for your practice — with a transition plan built in? Federally guaranteed passive income, post-sale, with potential tax advantage over an all-cash sale. The same instrument pension funds and Berkshire hold by the trillions — and among the most liquid in the world.
The buyer pool is wide and growing, the markets are public and regulated, and the structures we can build are nearly limitless.
Most groups that approach practice owners want enormous time investment before they'll quote a number — weeks of meetings, financial disclosures, exclusivity agreements, letters of intent. We don't work that way.
You sign a simple engagement letter. You introduce us to your books. From there, we do the rest. The next time we need you is when we have a real number to show you. By then, you've probably spent less than an hour of your time.
Until you accept an offer, your practice stays 100% yours. No exposure. No exclusivity. No obligation to do anything. When you see the full offer — every number, every term. You take it or you don't.
Hover any item to see what it involves.Tap any item to see what it involves.
A financial and operational read of your practice as a sellable asset — cash flow patterns, growth trajectory, risk profile, comparable benchmarks. Typically 20–40 hours of analyst work, the kind of analysis institutional buyers expect to see before underwriting.
Translating your practice into the standardized format institutional buyers can underwrite. Includes financial normalization, risk categorization, and projection modeling. Roughly 15–30 hours per practice.
Connecting your practice's books into our enterprise resource planning system so all twenty practices report as one unified institutional asset. This is the infrastructure that makes the entire portfolio model possible — and it's invisible to your day-to-day operations.
The same audit standard public companies are held to. Roughly 60–80 hours of senior-level audit work, coordinated at the portfolio level. Saves each practice an estimated $30,000–$50,000.
Know-Your-Customer documentation that institutional buyers legally require before deploying capital. We handle the paperwork, the verifications, and the ongoing compliance — work that would otherwise require specialized legal counsel.
Sourcing, qualifying, and aligning institutional buyers — pension funds, sovereign wealth, large asset managers — to your portfolio's specific composition. The work that turns “a stack of practices” into “a sellable institutional asset.”
Designing the legal entity, ownership structure, and governance framework of the portfolio itself. Typically requires coordination across securities counsel, tax counsel, and the institutional buyer's legal team.
Designing the legal, tax, and financial structure that determines how you actually receive your payout — whether cash, equity, Treasury-backed income, or a hybrid. Typically 80–120 hours of structuring work with tax counsel and securities lawyers.
Drafting and negotiating every transaction document — purchase agreements, side letters, equity grants, income vehicle paperwork. Work that would cost a solo practice $40,000–$80,000 in outside legal fees.
Managing the simultaneous closing across all twenty practices, the institutional buyer, and the portfolio entity. Synchronizing twenty deals into one transaction event.
Final disbursement of cash, equity, or income vehicle assets into your account or chosen structure. The day the deal becomes real.
You give us an hour.
We give you 800.
The current portfolio is targeted to close in early fall 2026. Conversations starting now still have time. Conversations starting late summer may not.
You've seen how this works.
The next step is a conversation